CRVO
CervoMed Inc.
2.50$
-0.8%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +63.2% | -5.8% | +40.1% | -41.0% | +11.4% | -11.3% | -8.3% | -81.6% | -97.3% | -100.0% | – | – | |
| – | +59.4% | -1.4% | +185.9% | -36.3% | +38.3% | -31.7% | – | – | – | – | – | – | |
| – | – | – | – | -196.8% | – | – | – | – | – | – | – | – | |
| – | +59.4% | -1.4% | +34.0% | +35.9% | +38.3% | -31.7% | +5.6% | +18.2% | -3.5% | -11.9% | -15.8% | – | |
| – | -12.2% | +0.6% | +18.0% | -12.0% | +4.8% | +2.9% | +37.1% | -28.8% | +7.9% | +18.5% | -20.8% | – | |
| – | -7.3% | +4.6% | +15.4% | +80.2% | +34.2% | -26.8% | +24.8% | +26.5% | -0.4% | -2.7% | -17.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -209.9% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -100.0% | -50.0% | – | – | – | – | – | – | – | – | – | |
| – | -209.9% | – | – | – | – | – | – | – | – | – | – | – | |
| – | +47.0% | -179.6% | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.